| # | Title | Journal | Year | Citations |
|---|
| 1 | Quantifying tumour heterogeneity with CT | Cancer Imaging | 2013 | 304 |
| 2 | Diffusion-weighted magnetic resonance imaging and its application to cancer | Cancer Imaging | 2006 | 293 |
| 3 | Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage | Cancer Imaging | 2010 | 278 |
| 4 | CT texture analysis using the filtration-histogram method: what do the measurements mean? | Cancer Imaging | 2013 | 253 |
| 5 | Ultrasound of malignant cervical lymph nodes | Cancer Imaging | 2008 | 225 |
| 6 | Computer aided detection (CAD): an overview | Cancer Imaging | 2005 | 192 |
| 7 | Imaging of liver metastases: MRI | Cancer Imaging | 2007 | 177 |
| 8 | 68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report | Cancer Imaging | 2016 | 171 |
| 9 | NELSON lung cancer screening study | Cancer Imaging | 2011 | 162 |
| 10 | Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings | Cancer Imaging | 2020 | 145 |
| 11 | Imaging of salivary gland tumours | Cancer Imaging | 2007 | 143 |
| 12 | Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring | Cancer Imaging | 2012 | 142 |
| 13 | 68Ga-DOTATATE and 18F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity | Cancer Imaging | 2016 | 135 |
| 14 | Defining the tumour and target volumes for radiotherapy | Cancer Imaging | 2004 | 133 |
| 15 | Neuroblastoma in childhood: review and radiological findings | Cancer Imaging | 2005 | 129 |
| 16 | Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T | Cancer Imaging | 2012 | 125 |
| 17 | Pre-surgical high resolution ultrasound of facial basal cell carcinoma: correlation with histology | Cancer Imaging | 2008 | 124 |
| 18 | Warburg revisited: imaging tumour blood flow and metabolism | Cancer Imaging | 2008 | 122 |
| 19 | Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma | Cancer Imaging | 2012 | 122 |
| 20 | CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation | Cancer Imaging | 2019 | 120 |
| 21 | Gastric carcinoma: imaging diagnosis, staging and assessment of treatment response | Cancer Imaging | 2013 | 116 |
| 22 | Quantitative 177 Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system | Cancer Imaging | 2011 | 111 |
| 23 | How to develop a meaningful radiomic signature for clinical use in oncologic patients | Cancer Imaging | 2020 | 110 |
| 24 | Imaging of sinonasal tumours | Cancer Imaging | 2012 | 106 |
| 25 | Neurosurgical applications of MRI guided laser interstitial thermal therapy (LITT) | Cancer Imaging | 2019 | 105 |
| 26 | Typical and atypical metastatic sites of recurrent endometrial carcinoma | Cancer Imaging | 2013 | 102 |
| 27 | Review of ultrasonography of malignant neck nodes: greyscale, Doppler, contrast enhancement and elastography | Cancer Imaging | 2013 | 102 |
| 28 | Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents | Cancer Imaging | 2007 | 101 |
| 29 | The effect of tamoxifen on the genital tract | Cancer Imaging | 2008 | 101 |
| 30 | CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis | Cancer Imaging | 2019 | 100 |
| 31 | Intensity-modulated radiotherapy - what is it? | Cancer Imaging | 2004 | 98 |
| 32 | Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging | Cancer Imaging | 2015 | 97 |
| 33 | Tumours of the spleen | Cancer Imaging | 2005 | 94 |
| 34 | Nodal staging | Cancer Imaging | 2009 | 94 |
| 35 | Imaging of malignancies of the biliary tract- an update | Cancer Imaging | 2014 | 94 |
| 36 | Neuroblastoma and nephroblastoma: a radiological review | Cancer Imaging | 2015 | 93 |
| 37 | Mucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review | Cancer Imaging | 2013 | 92 |
| 38 | Staging of neuroendocrine tumours: comparison of [68Ga]DOTATOC multiphase PET/CT and whole-body MRI | Cancer Imaging | 2013 | 91 |
| 39 | Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction | Cancer Imaging | 2019 | 90 |
| 40 | Liver cancer imaging: role of CT, MRI, US and PET | Cancer Imaging | 2004 | 89 |
| 41 | The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives | Cancer Imaging | 2014 | 87 |
| 42 | Ultrasound of thyroid cancer | Cancer Imaging | 2005 | 86 |
| 43 | Review: Primary and secondary neoplasms of the spleen | Cancer Imaging | 2010 | 86 |
| 44 | Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations | Cancer Imaging | 2016 | 86 |
| 45 | Comparison of efficacy and complications of endoscopic and percutaneous biliary drainage in malignant obstructive jaundice: a systematic review and meta-analysis | Cancer Imaging | 2017 | 85 |
| 46 | CT perfusion in oncology: how to do it | Cancer Imaging | 2010 | 84 |
| 47 | Diffusion-weighted and diffusion tensor imaging of the brain, made easy | Cancer Imaging | 2010 | 84 |
| 48 | Renal and adrenal tumours in children | Cancer Imaging | 2007 | 83 |
| 49 | Imaging of the unusual pediatric 'blastomas' | Cancer Imaging | 2009 | 83 |
| 50 | CT, MRI and PET imaging in peritoneal malignancy | Cancer Imaging | 2011 | 81 |
